Agilent Technologies (NYSE:A) released its quarterly earnings data on Monday. The medical research company reported $0.89 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.03, RTT News reports. The firm had revenue of $1.37 billion during the quarter, compared to the consensus estimate of $1.33 billion. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The firm’s revenue was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.81 earnings per share. Agilent Technologies updated its Q1 guidance to $0.80-0.81 EPS and its FY20 guidance to $3.38-3.43 EPS.
A stock traded up $1.14 during mid-day trading on Monday, reaching $80.26. The company had a trading volume of 2,639,825 shares, compared to its average volume of 2,209,196. The company has a quick ratio of 1.72, a current ratio of 2.13 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $24.23 billion, a P/E ratio of 28.77, a P/E/G ratio of 1.94 and a beta of 1.42. Agilent Technologies has a one year low of $62.00 and a one year high of $82.27. The stock’s 50-day simple moving average is $76.30 and its two-hundred day simple moving average is $72.89.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.90%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.16. The ex-dividend date of this dividend is Monday, December 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.
In related news, CEO Michael R. Mcmullen sold 24,635 shares of Agilent Technologies stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $77.50, for a total transaction of $1,909,212.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Heidi Fields sold 4,000 shares of Agilent Technologies stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $78.56, for a total transaction of $314,240.00. Following the sale, the director now owns 53,287 shares in the company, valued at $4,186,226.72. The disclosure for this sale can be found here. Insiders sold 32,635 shares of company stock worth $2,507,293 over the last quarter.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Story: Stock Symbols and CUSIP Explained
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.